Liver transplant study may unlock clues to artery hardening
NCT ID NCT03576859
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This pilot study looked at 38 liver transplant patients to see if liver failure lowers blood levels of pyrophosphate, a natural substance that prevents calcium buildup in tissues. Researchers measured pyrophosphate before and after transplant and checked liver tissue for a related gene (ABCC6). The goal is to understand why people with fatty liver disease often develop vascular calcification.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could reveal why people with fatty liver disease often develop hardened arteries, pointing toward new ways to prevent or treat vascular calcification.
- What could go wrong
- This is a small pilot study with only 38 participants, so results may not apply to everyone. It is designed to gather knowledge, not to test a treatment.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEPATIC FAILURE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Untiversity Hospital of Nice
Nice, 06000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.